GLP1 Guide
Publishes 1 feed
GLP1 Guide
The latest research and information on GLP1 Receptor Agonists (Ozempic, Wegovy, Mounjaro, Zepbound , etc) and their effects on type 2 diabetes, weight loss, and heart disease.
11 posts · theirs
Lately
📅 Last week in GLP1 (2026/08/24)
📅 Last week in GLP1 (2026/08/17)
📅 Last week in GLP1 (2026/08/10)
📅 Last week in GLP1 (2026/08/03)
🚨 Australia adds warning labels to GLP1s for NAION (blinding disease)
🌊 The GLP1 wave continues to pitch and roll
📅 Last week in GLP1 (2026/07/27)
☀️ Slow summer? Not in GLP1 land
📅 Last week in GLP1 (2026/07/20)
📅 Last week in GLP1 (2026/07/13)
🧬 How is GLP1 gene therapy progressing?
Everything on this page was read from markup GLP1 Guide published — a rel="me" link, an h-card, or the feed’s own author element. Nothing was inferred from anywhere else. To correct or remove it, get in touch. Machine-readable: JSON
